HQL offers a high 12% yield and trades at a discount, making it attractive for income-focused investors seeking healthcare sector exposure. The fund is heavily weighted in biotechnology, leading to ...
abrdn Life Sciences Investors remains a buy for high-yield seekers, offering a 10.1% dividend yield and diversified healthcare exposure. HQL trades at a 7.92% discount to NAV, with its share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results